Yasuki Kamai Selected Research

R-120758

6/2010	Design, synthesis and antifungal activity of the novel water-soluble prodrug of antifungal triazole CS-758.
7/2009	Synthesis, cleavage, and antifungal activity of a number of novel, water-soluble ester prodrugs of antifungal triazole CS-758.
2/2003	Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice.
2/2002	In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuki Kamai Research Topics

Disease

6	Infections 06/2010 - 02/2002
3	Candidiasis (Moniliasis) 01/2005 - 02/2002
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
2	Neoplasms (Cancer) 12/2019 - 01/2019
2	Aspergillosis 01/2009 - 02/2002
1	Invasive Pulmonary Aspergillosis 01/2009
1	Chronic Mucocutaneous Candidiasis 01/2004
1	Body Weight (Weight, Body) 02/2003
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2003
1	Cryptococcosis 02/2002

Drug/Important Bio-Agent (IBA)

4	R-120758IBA 06/2010 - 02/2002
4	Fluconazole (Zonal)FDA LinkGeneric 01/2005 - 01/2003
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	patritumab deruxtecanIBA 12/2019
1	lorlatinibIBA 01/2019
1	entrectinibIBA 01/2019
1	CrizotinibIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	E-SelectinIBA 01/2009
1	Thromboplastin (Tissue Factor)IBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Interleukin-8 (Interleukin 8)IBA 01/2009
1	GliotoxinIBA 01/2009
1	Phenobarbital (Luminal)FDA Link 01/2009
1	R 135853IBA 01/2005
1	sordarinIBA 01/2005
1	Dihydrotachysterol (AT 10)IBA 02/2003
1	TriazolesIBA 02/2003
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2003

Therapy/Procedure

1	Therapeutics 12/2019